Cervical cancer kills nearly 80,000 Indian women every year-lives lost to a disease that is not only preventable but preventable with a single vaccine.
Few health threats in India present such a clear problem and such a clear solution. That solution is the HPV vaccine: safe, well studied, and capable of stopping the virus that causes almost all cervical cancer.
What Families Should Know About HPV
The Human Papillomavirus, or HPV, is the most common viral infection spread through intimate skin to skin contact. Almost every sexually active person will encounter it at some point. Because it often causes no symptoms, many people carry and transmit the virus unknowingly. Most infections clear naturally. The danger lies in the small number that don’t. When high risk HPV strains persist, they can slowly begin to cause cellular changes that, over 10 to 20 years, may develop into cancer.
This long, silent progression is why cervical cancer so often appears late-and why it is so deadly in India. Screening rates remain extremely low, leaving most women unprotected until the disease has advanced.
Prevention Before Infection
The HPV vaccine is one of the most powerful cancer prevention tools ever developed. It is a non live vaccine and cannot cause HPV infection. Instead, it trains the immune system to block the virus before it can ever take hold. Global experience is unequivocal: countries that introduced the vaccine early have seen sharp declines in HPV infections, precancerous lesions, and cervical cancer. After hundreds of millions of doses administered worldwide, the vaccine has an outstanding safety record, with only mild, short lived side effects. India has been slower to adopt widespread HPV vaccination-but that is now changing.
India’s Landmark Step Forward
Beginning March 2026, the Government of India will launch a nationwide campaign to offer free HPV vaccination to all 14 year old girls. This age is chosen for a simple scientific reason: the vaccine works best before any possible exposure to HPV.
The programme will use a single dose of the quadrivalent vaccine Gardasil 4, which protects against the two HPV types responsible for most cervical cancers, as well as two types that cause genital warts. The scale is unprecedented. Every year, India has over one crore girls entering this age group. With this campaign, every one of them will now have access to effective, evidence based protection-free of cost.
Registration and appointments will be handled through U WIN, the digital platform modeled on the successful CoWIN system. This is not just a vaccination drive. It is one of the largest cancer prevention initiatives ever undertaken.
What About Boys?
While the government’s initial rollout focuses on girls, scientific consensus strongly supports vaccinating boys too. HPV does not only cause cervical cancer; it is also responsible for cancers of the throat, anus, and penis, as well as genital warts. Including boys reduces overall viral circulation and strengthens community wide protection.
Parents who can afford it may consider vaccinating boys through private providers, where multiple vaccine options are available.
A Moment of Responsibility and Opportunity
HPV vaccination is not about stigma, sexuality, or moral judgment. It is about prevention-pure and simple. It is about shielding our next generation from a cancer that devastates families, steals lives too early, and is overwhelmingly preventable. The science is clear. The vaccine is safe. It is effective. And from 2026 onward, it will be free and accessible for India’s adolescents.
For parents, this is a rare moment: a chance to prevent a deadly cancer before it ever begins. Cervical cancer has taken far too many lives in our country. With one dose, we now have the power to break that cycle. The question is no longer whether we should vaccinate. It is whether we can afford not to.
Dr Rakesh Chopra
Other articles about HPV Vaccine on OncoDaily.